<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(11)</volume><submitter>Chmiel C</submitter><funding>“Gottfried und Julia Bangerter-Rhyner-Stiftung”, fund of the Swiss Academy of Medical Sciences</funding><funding>Thermo Fisher Scientific</funding><funding>IBDnet, Swiss Research and Communication Network on Inflammatory Bowel Disease</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Diagnosis of inflammatory bowel disease (IBD) in primary care (PC) is challenging and associated with a considerable diagnostic delay. Using a calprotectin test for any PC patient with abdominal complaints would cause significant costs. The 8-item-questionnaire CalproQuest was developed to increase the pre-test probability for a positive Calprotectin. It is a feasible instrument to assess IBD in PC, but has not yet been evaluated in clinical routine. This study, therefore, aimed to validate whether the CalproQuest increases pretest-probability for a positive fecal Calprotectin.&lt;h4>Methods&lt;/h4>Prospective diagnostic trial. The CalproQuest consists of 4 major and 4 minor questions suggestive for IBD. It is considered positive if ≥ 2 major or 1 major and 2 minor criteria ar</pubmed_abstract><journal>PloS one</journal><pagination>e0224961</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6872045</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Can the CalproQuest predict a positive Calprotectin test? A prospective diagnostic study.</pubmed_title><pmcid>PMC6872045</pmcid><pubmed_authors>Sulz MC</pubmed_authors><pubmed_authors>Senn O</pubmed_authors><pubmed_authors>Tandjung R</pubmed_authors><pubmed_authors>Scherz N</pubmed_authors><pubmed_authors>Chmiel C</pubmed_authors><pubmed_authors>Zahnd N</pubmed_authors><pubmed_authors>Vavricka S</pubmed_authors><pubmed_authors>Hasler S</pubmed_authors><pubmed_authors>Rosemann T</pubmed_authors><pubmed_authors>Rogler G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Can the CalproQuest predict a positive Calprotectin test? A prospective diagnostic study.</name><description>&lt;h4>Background&lt;/h4>Diagnosis of inflammatory bowel disease (IBD) in primary care (PC) is challenging and associated with a considerable diagnostic delay. Using a calprotectin test for any PC patient with abdominal complaints would cause significant costs. The 8-item-questionnaire CalproQuest was developed to increase the pre-test probability for a positive Calprotectin. It is a feasible instrument to assess IBD in PC, but has not yet been evaluated in clinical routine. This study, therefore, aimed to validate whether the CalproQuest increases pretest-probability for a positive fecal Calprotectin.&lt;h4>Methods&lt;/h4>Prospective diagnostic trial. The CalproQuest consists of 4 major and 4 minor questions suggestive for IBD. It is considered positive if ≥ 2 major or 1 major and 2 minor criteria ar</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-04-04T13:27:57.091Z</modification><creation>2020-05-21T21:18:05Z</creation></dates><accession>S-EPMC6872045</accession><cross_references><pubmed>31751360</pubmed><doi>10.1371/journal.pone.0224961</doi></cross_references></HashMap>